The 3.75% convertible notes are due 2027

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by NextGen Healthcare, Inc. of $275 million aggregate principal amount of its 3.75% convertible senior notes due 2027, which included $45 million principal amount of notes pursuant to the exercise in full of the initial purchaser’s option to purchase additional notes.

NextGen Healthcare is a leading provider of innovative healthcare technology solutions. NextGen Healthcare is reimagining ambulatory healthcare with award-winning solutions that enable high-performing practices to create healthier communities. NextGen Healthcare partners with medical, behavioral and dental providers in their journey toward whole-person health and value-based care.

The Davis Polk corporate team included partner Yasin Keshvargar and associates Michael Jiang and Caroline Armstrong. The equity derivatives team included partner Mark M. Mendez and associates Gregory Edgar Marchesini, Danielle Forni and Eugenia S. Lee. Partner Michael Farber and associate Charles Collier provided tax advice. Partner David R. Bauer and associate Alison T. Chin provided intellectual property advice. All members of the Davis Polk team are based in the New York office.